Leukemia Lymphoma Society

Leukemia Lymphoma Society Article

Chronic myelogenous leukemia Classifications and external resources The Philadelphia chromosome as seen by metaphase FISH. ICD-10 C92.1 ICD-9 205.1 ICD-O: M9863/3 DiseasesDB 2659 MedlinePlus 000570 eMedicine med/371

Leukemia Lymphoma Society News

Tribute to Jacqueline Kennedy Onassis Focuses Attention on the Need for Blood Cancer Cures; As Hundreds of Cancer Advocates Descend on Capitol Hill, The Leukemia & Lymphoma Society Announces Year-Long Patient Education Series on the Cancer That Claimed Onassis' Life.

WHITE PLAINS, N.Y., March 4 /PRNewswire/ - The Leukemia & Lymphoma Society, marking the 10 years that have past since the death of Jacqueline Kennedy Onassis, today announced a first-of-its-kind, year-long patient education program on non-Hodgkin lymphoma, the cancer that claimed Onassis'

The Leukemia & Lymphoma Society's Career Development Program Enables Researchers to Focus on New Cancer Treatments and Cures; New Grants Bring the Program's Total Investment to $138 Million.

WHITE PLAINS, N.Y., April 30 /PRNewswire/ - The Leukemia & Lymphoma Society today announced 70 Career Development Program grants totaling $14.9 million. The grants, which allow scientists at different stages of their careers to devote themselves to leukemia, lymphoma and myeloma research,

Cancer Drug Velcade Holds Promise for a Novel Treatment of Mantle Cell Lymphoma; New Research, Funded by The Leukemia & Lymphoma Society, Finds Velcade Causes Natural Cell Death of Lymphocytes by Inhibiting a Key Growth Signaling Pathway.

WHITE PLAINS, N.Y. - WHITE PLAINS, N.Y., June 20 /PRNewswire/ - New research funded by The Leukemia & Lymphoma Society found that Millennium Pharmaceutical's cancer drug, Velcade (bortezomib), recently approved by the U.S. Food and Drug Administration for the treatment of multiple myeloma,

The Leukemia & Lymphoma Society Awards Grants to Researchers on the Forefront Of New Cancer Treatments; Translational Research Program Poised to Break $100 Million in Funding.

WHITE PLAINS, N.Y., Sept. 8 /PRNewswire/ - The Leukemia & Lymphoma Society today announced 32 Translational Research Program grants totaling $11.3 million to researchers on the forefront of developing new treatments for leukemia, lymphoma and myeloma. The awards bring the program's total

Fred Hutchinson Research Center Awarded $7 Million Grant To Lead Cancer Research Initiative; Investigation Is Part of The Leukemia & Lymphoma Society's $52 Million Global Research Program that Seeks to Find Cures for Blood Cancers.

WHITE PLAINS, N.Y. - The Leukemia & Lymphoma Society (the Society) announced it has awarded a $7 million grant through its Specialized Center of Research (SCOR) program to Dr. Irwin Bernstein, head of pediatric oncology research at the Fred Hutchinson Cancer Research Center in Seattle. Dr.